Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid Tumors

NCT05868174 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor, Adult
Advanced Solid Tumor
Advanced Renal Cell Carcinoma

Interventions

DIAGNOSTIC_TEST: 89Zr-TLX250
COMBINATION_PRODUCT: 177Lu-TLX250 and Peposertib

Sponsor

Telix Pharmaceuticals (Innovations) Pty Limited

Collaborators

[object Object]